XML 50 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments (Tables)
12 Months Ended
Dec. 31, 2024
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments  
Schedule of marketable investment securities, restricted cash and cash equivalents, and other investments

​

​

​

​

​

​

​

​

​

​

​

​

​

As of December 31,

​

    

2024

    

2023

​

​

(In thousands)

Marketable investment securities:

​

​

​

​

​

​

Current marketable investment securities:

​

​

​

​

​

​

Strategic - available-for-sale

​

$

51

​

$

144

Strategic - trading/equity

​

​

26,454

​

​

176,205

Other

​

​

1,215,531

​

​

446,695

Total current marketable investment securities

​

​

1,242,036

​

​

623,044

Restricted marketable investment securities (1)

​

​

32,114

​

​

27,840

Total marketable investment securities

​

​

1,274,150

​

​

650,884

​

​

​

​

​

​

​

Restricted cash and cash equivalents (1)

​

​

288,411

​

​

90,225

​

​

​

​

​

​

​

Other investments, net:

​

​

​

​

​

​

Equity method investments (2)

​

​

83,423

​

​

169,038

Cost method investments

​

​

106,811

​

​

106,134

Fair value method and other debt investments (3)

​

​

12,093

​

​

39,198

Total other investments, net

​

​

202,327

​

​

314,370

​

​

​

​

​

​

​

Total marketable investment securities, restricted cash and cash equivalents, and other investments, net

​

$

1,764,888

​

$

1,055,479

(1)Restricted marketable investment securities and restricted cash and cash equivalents are included in “Current restricted cash and cash equivalents” and “Restricted cash, cash equivalents and marketable investment securities” on our Consolidated Balance Sheets and discussed below.
(2)The decrease primarily resulted from our Invidi Technologies Corporation and Broadband Connectivity Solutions (Restricted) Limited investments, discussed below.
(3)The decrease primarily resulted from a $27 million impairment in a fair value method investment during the year ended December 31, 2024 and recorded in “Other, net” on our Consolidated Statements of Operations and Comprehensive Income (Loss).
Schedule of fair value measurements

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As of December 31,

​

​

2024

​

2023

​

    

Total  

    

Level 1

    

Level 2

    

Level 3

    

Total  

    

Level 1

    

Level 2

    

Level 3

​

​

(In thousands)

Cash equivalents (including restricted)

​

$

3,999,150

​

$

255,118

​

$

3,744,032

​

$

—

​

$

1,692,849

​

$

573,504

​

$

1,119,345

​

$

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Debt securities (including restricted):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

U.S. Treasury and agency securities

​

$

8,163

​

$

8,163

​

$

—

​

$

—

​

$

65,172

​

$

65,172

​

$

—

​

$

—

Commercial paper

​

​

596,568

​

​

—

​

​

596,568

​

​

—

​

​

290,398

​

​

—

​

​

290,398

​

​

—

Corporate securities

​

​

629,115

​

​

—

​

​

629,115

​

​

—

​

​

114,265

​

​

—

​

​

114,265

​

​

—

Other

​

​

13,850

​

​

—

​

​

13,799

​

​

51

​

​

4,844

​

​

—

​

​

4,700

​

​

144

Equity securities

​

​

26,454

​

​

26,454

​

​

—

​

​

—

​

​

176,205

​

​

166,481

​

​

9,724

​

​

—

Total

​

$

1,274,150

​

$

34,617

​

$

1,239,482

​

$

51

​

$

650,884

​

$

231,653

​

$

419,087

​

$

144

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Schedule of gains and losses on sales and changes in carrying amounts of investments and other

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Years Ended December 31,

Other, net:

    

2024

    

2023

    

2022

 

​

(In thousands)

Marketable and non-marketable investment securities - realized and unrealized gains (losses)

​

$

(73,217)

​

$

13,664

​

$

73,293

Derivative instruments - net realized and/or unrealized gains (losses)

​

​

—

​

​

(1,793,387)

​

​

1,015,387

Other investment securities - other-than-temporary impairments

​

​

—

​

​

(39,800)

​

​

—

Gains (losses) related to early redemption of debt

​

​

—

​

​

73,024

​

​

(922)

Foreign currency transaction gains (losses)

​

​

(4,511)

​

​

5,677

​

​

5,235

Equity in earnings (losses) of affiliates

​

​

(73,451)

​

​

(8,098)

​

​

(3,087)

Liberty Puerto Rico Asset Sale gains (losses) (Note 15)

​

​

50,418

​

​

—

​

​

—

EchoStar Exchange Offers debt extinguishment gains (losses) (Note 10)

​

​

688,661

​

​

—

​

​

—

Other

​

​

5,597

​

​

(21,872)

​

​

(1,465)

Total

​

$

593,497

​

$

(1,770,792)

​

$

1,088,441

​

​

​

​

​

​

​

​

​

​

​